Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 15, 2019 - Issue 11
Submit an article Journal homepage
656
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Reply to the Letter: ‘Thrombotic microangiopathy in adult-onset Still’s disease: the story is just beginning’

Stéphane MitrovicDepartment of Rheumatology, AP-HP, Hôpital de La Pitié Salpêtrière, Sorbonne Université, Paris, France;Department of Internal Medicine, Institut Mutualiste Montsouris, Paris, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5244-7881View further author information
ORCID Icon,
Alexandre HertigDepartment of Renal Transplantation, AP-HP, Hôpital de La Pitié Salpêtrière, Sorbonne Université, Paris, FranceORCID Iconhttps://orcid.org/0000-0002-2903-3303View further author information
ORCID Icon &
Bruno FautrelDepartment of Rheumatology, AP-HP, Hôpital de La Pitié Salpêtrière, Sorbonne Université, Paris, France;Faculté de Médecine et Institut Pierre Louis d’Epidémiologie et Santé publique, Sorbonne Université, Paris, France;CRI-IMIDIATE, a FCRIN Clinical Research Network, FranceORCID Iconhttps://orcid.org/0000-0001-8845-4274View further author information
ORCID Icon
Pages 1125-1126 | Published online: 31 Oct 2019

References

  • Rafat C, Luque Y. Thrombotic microangiopathy in adult-onset Still’s disease: the story is just beginning. Expert Rev Clin Immunol. 2019. DOI:10.1080/1744666X.2019.1682892
  • Mitrovic S, Fautrel B. Complications of adult-onset Still’s disease and their management. Expert Rev Clin Immunol. 2018 May;14(5):351–365.
  • Hirata S, Okamoto H, Ohta S, et al. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura in the setting of adult-onset Still’s disease. Rheumatology (Oxford). 2006 Aug;45(8):1046–1047. Epub 2006 May 23.
  • Roriz M, Landais M, Desprez J, et al. Risk factors for autoimmune diseases development after thrombotic thrombocytopenic purpura. Medicine (Baltimore). 2015 Oct;94(42):e1598.
  • Coppo P, Schwarzinger M, Buffet M, et al. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. PLoS One. 2010 Apr 23;5(4):e10208.
  • Joly BS, Boisseau P, Roose E, et al. ADAMTS13 gene mutations influence ADAMTS13 conformation and disease age-onset in the French Cohort of upshaw-schulman syndrome. Thromb Haemost. 2018 Nov;118(11):1902–1917. Epub 2018 Oct 12.
  • Kello N, Khoury LE, Marder G, et al. Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: case series and review of literature. Semin Arthritis Rheum. 2019 Aug;49(1):74–83.
  • Dragon-Durey MA, Blanc C, Marliot F, et al. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. J Med Genet. 2009 Jul;46(7):447–450. Epub 2009 May 11.
  • Page EE, Little DJ, Vesely SK, et al. Quinine-induced thrombotic microangiopathy: a report of 19 patients. Am J Kidney Dis. 2017 Nov;70(5):686–695.
  • Feist E, Mitrovic S, Fautrel B. Mechanisms, biomarkers and targets for adult-onset Still’s disease. Nat Rev Rheumatol. 2018 Oct;14(10):603–618.
  • El Karoui K, Karras A, Lebrun G, et al. Thrombotic microangiopathy and purtscher-like retinopathy associated with adult-onset Still’s disease: a role for glomerular vascular endothelial growth factor? Arthritis Rheum. 2009 Nov 15;61(11):1609–1613.
  • Sumida K, Ubara Y, Hoshino J, et al. Etanercept-refractory adultonset Still’s disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab. Clin Rheumatol. 2010 Oct;29(10):1191–1194. Epub 2010 Mar 12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.